首页> 外文期刊>Journal of Biodiversity, Bioprospecting and Development >Evaluation of Anti-Diabetic Property of Extracts of Different Plant Parts of Salacia chinensis Linn.
【24h】

Evaluation of Anti-Diabetic Property of Extracts of Different Plant Parts of Salacia chinensis Linn.

机译:ala藜不同植物部位提取物的抗糖尿病性能评价。

获取原文
           

摘要

Plants from the Western Ghats Mountains (a global biodiversity hot-spot) in western India are increasingly gaining importance for their newfound disease curative properties. One such example is an extract of the plant, Salacia chinensis Linn, the compound Salacinol which (along with related compounds) is increasingly being used in the treatment of diabetes. Of late, demand for this extract has increased at a rapid pace, leading to widespread overharvesting of Salacia roots (the plant part predominantly used for extraction) and consequent population decline by over 50%. Such overexploitation in a global?biodiversity hotspot threatens the ecological sustainability of this fragile ecosystem and global health care, as well as local livelihoods. One strategy to relieve the harvest pressure on wild population while attempting to cater to the ever increasing demand of raw material by the pharmaceutical industry is to utilize alternative plant parts and raise viable commercial cultivation. With a view to developing a sustainable harvest?strategy, this paper presents an assessment of anti-diabetic activity of alternative plant parts (stems, seeds, leaves). We present the results of in vitro evaluation of α- glucosidase inhibition activity by S. chinensis extracts with respect to parameters like plant part, age of plant and effective solvent system. Promising α- glucosidase enzyme inhibition results were obtained from crude extracts of stems and seeds. The highest inhibition levels demonstrated by aqueous extracts of roots and stems were 80.43 ± 1.14 % (IC50-22.17 μg/ml) and 81.2 ± 0.41 % (IC50- 22.23 μg/ml) respectively, whereas for successive aqueous extracts of seeds inhibition levels were 56.0 ± 1.30 % (IC50-79.04 μg/ml). By demonstrating that stems and seeds of S. chinensis can be used as an alternative to roots, our study has the potential to form the basis for a sustainable path forward for the harvesting of this plant for medicinal purposes.
机译:印度西部的西高止山脉(全球生物多样性热点)的植物因其新发现的疾病治疗特性而变得越来越重要。这样的例子之一是植物Salacia chinensis Linn的提取物,其为化合物Salacinol(以及相关化合物)正越来越多地用于治疗糖尿病。最近,对该提取物的需求迅速增长,导致对Salacia根(主要用于提取的植物部分)的广泛超采,因此种群减少了50%以上。全球生物多样性热点地区的这种过度开发威胁着这个脆弱的生态系统和全球卫生保健以及当地生计的生态可持续性。在试图满足制药业对原材料不断增长的需求的同时,缓解野生种群收获压力的一种策略是利用替代植物部分并提高可行的商业种植。为了制定可持续的收获策略,本文提出了对植物其他部位(茎,种子,叶)的抗糖尿病活性的评估。我们提出了关于中华参提取物对α-葡萄糖苷酶抑制活性的体外评估结果,涉及植物部分,植物年龄和有效溶剂系统等参数。从茎和种子的粗提物中获得有希望的α-葡萄糖苷酶抑制结果。根和茎的水提物显示的最高抑制水平分别为80.43±1.14%(IC50-22.17μg/ ml)和81.2±0.41%(IC50-22.23μg/ ml),而对于连续的水提物,种子的抑制水平为56.0±1.30%(IC50-79.04μg/ ml)。通过证明中国五味子的茎和种子可以替代根,我们的研究有可能为该药用植物的收获可持续发展道路奠定基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号